April 8th, 2025 |
Kavita Patel |
Director |
Exercise Sale
|
4.50K |
$106.23K |
31.58K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Sale
|
1500 |
$57.50 |
$86.25K |
|
March 20th, 2025 |
Kristin Myers |
Director |
Stock Award
|
16.83K |
$1.18M |
16.83K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
16829 |
$69.87 |
$1.18M |
|
March 20th, 2025 |
Andrew Galligan |
Director |
Stock Award
|
16.83K |
$1.18M |
16.83K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
16829 |
$69.87 |
$1.18M |
|
March 20th, 2025 |
Kristin Myers |
|
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
March 20th, 2025 |
Andrew Galligan |
Director |
|
- |
$- |
5.00K |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
|
0 |
$0.00 |
$- |
|
March 18th, 2025 |
Kavita Patel |
Director |
Exercise Sale
|
4.50K |
$127.44K |
33.08K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Sale
|
1500 |
$71.64 |
$107.46K |
|
February 27th, 2025 |
Rami Elghandour |
Director, Officer: See Remarks |
Stock Award
|
1.02M |
$- |
1.16M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
347255 |
$0.00 |
$- |
Common Stock |
Stock Award
|
668416 |
$0.00 |
$- |
|
February 26th, 2025 |
Rami Elghandour |
Director, Officer: See Remarks |
Sale
|
38.30K |
$2.38M |
181.15K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
6334 |
$61.14 |
$387.25K |
Common Stock |
Sale
|
21077 |
$61.95 |
$1.31M |
Common Stock |
Sale
|
10889 |
$62.69 |
$682.62K |
|
February 25th, 2025 |
Kavita Patel |
Director |
Exercise Sale
|
4.50K |
$114.72K |
34.58K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Sale
|
1500 |
$63.16 |
$94.74K |
|
February 24th, 2025 |
Christopher Heery |
Chief Medical Officer |
Sale
|
10.15K |
$647.77K |
43.27K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
4370 |
$63.14 |
$275.92K |
Common Stock |
Sale
|
5577 |
$64.26 |
$358.36K |
Common Stock |
Sale
|
208 |
$64.88 |
$13.49K |
|
February 11th, 2025 |
Christopher Heery |
Chief Medical Officer |
Exercise
|
45.11K |
$- |
47.64K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
22556 |
$0.00 |
$- |
Restricted Stock Unit |
Exercise/Conversion
|
22556 |
$0.00 |
$- |
|
February 11th, 2025 |
Rami Elghandour |
Director, Officer: See Remarks |
Exercise
|
140.42K |
$- |
187.49K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
70211 |
$0.00 |
$- |
Restricted Stock Unit |
Exercise/Conversion
|
70211 |
$0.00 |
$- |
|
February 4th, 2025 |
Kavita Patel |
Director |
Exercise Sale
|
4.50K |
$116.83K |
36.08K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Sale
|
1500 |
$64.57 |
$96.85K |
|
January 14th, 2025 |
Kavita Patel |
Director |
Exercise Sale
|
4.50K |
$118.78K |
37.58K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Sale
|
800 |
$64.95 |
$51.96K |
Common Stock |
Sale
|
400 |
$66.62 |
$26.65K |
Common Stock |
Sale
|
300 |
$67.32 |
$20.20K |
|
January 10th, 2025 |
Christopher Heery |
Chief Medical Officer |
Sale
|
7.78K |
$581.32K |
28.64K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
4230 |
$75.53 |
$319.48K |
Common Stock |
Sale
|
3553 |
$73.69 |
$261.83K |
|
January 10th, 2025 |
Michelle Gilson |
Chief Financial Officer |
Sale
|
18.01K |
$1.36M |
24.46K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
3128 |
$74.43 |
$232.81K |
Common Stock |
Sale
|
1546 |
$75.23 |
$116.31K |
Common Stock |
Sale
|
2251 |
$76.64 |
$172.52K |
Common Stock |
Sale
|
2327 |
$77.06 |
$179.32K |
Common Stock |
Sale
|
4760 |
$75.53 |
$359.51K |
Common Stock |
Sale
|
3997 |
$73.69 |
$294.55K |
|
January 10th, 2025 |
Rami Elghandour |
Director, Officer: See Remarks |
Sale
|
30.31K |
$2.26M |
131.11K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
16474 |
$75.53 |
$1.24M |
Common Stock |
Sale
|
13837 |
$73.69 |
$1.02M |
|
January 10th, 2025 |
Christopher Heery |
Chief Medical Officer |
Sale
|
5.95K |
$466.23K |
35.84K |
Form 4/A
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
2975 |
$79.55 |
$236.66K |
Common Stock |
Sale
|
2975 |
$77.17 |
$229.57K |
|
January 10th, 2025 |
Michelle Gilson |
Chief Financial Officer |
Exercise Sale
|
31.74K |
$880.97K |
40.99K |
Form 4/A
|
Security |
Transaction |
Shares |
Price |
Value |
Restricted Stock Units |
Exercise/Conversion
|
20495 |
$0.00 |
$- |
Common Stock |
Sale
|
5622 |
$79.55 |
$447.22K |
Common Stock |
Sale
|
5621 |
$77.17 |
$433.75K |
|
January 10th, 2025 |
Rami Elghandour |
Director, Officer: See Remarks |
Sale
|
30.22K |
$2.37M |
162.70K |
Form 4/A
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
15112 |
$79.55 |
$1.20M |
Common Stock |
Sale
|
15111 |
$77.17 |
$1.17M |
|
January 6th, 2025 |
Michelle Gilson |
Chief Financial Officer |
Stock Award Exercise Sale
|
164.39K |
$831.38K |
82.12K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Restricted Stock Unit |
Stock Award
|
82120 |
$0.00 |
$- |
Restricted Stock Unit |
Exercise/Conversion
|
20495 |
$0.00 |
$- |
Common Stock |
Exercise/Conversion
|
15339 |
$0.00 |
$- |
Common Stock |
Sale
|
5502 |
$79.55 |
$437.67K |
Common Stock |
Sale
|
5102 |
$77.17 |
$393.71K |
Common Stock |
Exercise/Conversion
|
20495 |
$0.00 |
$- |
Restricted Stock Unit |
Exercise/Conversion
|
15339 |
$0.00 |
$- |
|
January 6th, 2025 |
Christopher Heery |
Chief Medical Officer |
Stock Award Exercise Sale
|
117.70K |
$498.80K |
52.26K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Restricted Stock Unit |
Stock Award
|
52258 |
$0.00 |
$- |
Common Stock |
Exercise/Conversion
|
16519 |
$0.00 |
$- |
Common Stock |
Sale
|
3301 |
$79.55 |
$262.59K |
Common Stock |
Sale
|
3061 |
$77.17 |
$236.21K |
Restricted Stock Unit |
Exercise/Conversion
|
13021 |
$0.00 |
$- |
Common Stock |
Exercise/Conversion
|
13021 |
$0.00 |
$- |
Restricted Stock Unit |
Exercise/Conversion
|
16519 |
$0.00 |
$- |
|
January 6th, 2025 |
Rami Elghandour |
Director, Officer: See Remarks |
Stock Award Exercise Sale
|
469.71K |
$2.24M |
223.96K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Restricted Stock Unit |
Stock Award
|
223964 |
$0.00 |
$- |
Common Stock |
Exercise/Conversion
|
53097 |
$0.00 |
$- |
Common Stock |
Sale
|
14857 |
$79.55 |
$1.18M |
Common Stock |
Sale
|
13776 |
$77.17 |
$1.06M |
Common Stock |
Exercise/Conversion
|
55459 |
$0.00 |
$- |
Restricted Stock Unit |
Exercise/Conversion
|
55459 |
$0.00 |
$- |
Restricted Stock Unit |
Exercise/Conversion
|
53097 |
$0.00 |
$- |
|
December 26th, 2024 |
Kavita Patel |
Director |
Exercise Sale
|
4.50K |
$135.43K |
39.08K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Sale
|
1400 |
$76.92 |
$107.69K |
Common Stock |
Sale
|
100 |
$77.61 |
$7.76K |
|
December 5th, 2024 |
Kavita Patel |
Director |
Exercise Sale
|
4.50K |
$157.80K |
40.58K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Sale
|
300 |
$88.53 |
$26.56K |
Common Stock |
Sale
|
400 |
$89.84 |
$35.94K |
Common Stock |
Sale
|
200 |
$91.91 |
$18.38K |
Common Stock |
Sale
|
300 |
$93.76 |
$28.13K |
Common Stock |
Sale
|
300 |
$96.05 |
$28.81K |
|
November 19th, 2024 |
Michelle Gilson |
Chief Financial Officer |
Exercise Sale
|
7.76K |
$208.47K |
78.31K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Exercise/Conversion
|
3000 |
$8.66 |
$25.98K |
Common Stock |
Exercise/Conversion
|
3000 |
$8.66 |
$25.98K |
Common Stock |
Sale
|
1061 |
$87.89 |
$93.26K |
Common Stock |
Sale
|
500 |
$89.17 |
$44.59K |
Common Stock |
Sale
|
100 |
$91.67 |
$9.17K |
Common Stock |
Sale
|
100 |
$95.00 |
$9.50K |
|
November 14th, 2024 |
Kavita Patel |
Director |
Exercise Sale
|
4.50K |
$179.47K |
42.08K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Exercise/Conversion
|
1500 |
$6.66 |
$9.99K |
Common Stock |
Sale
|
1500 |
$106.33 |
$159.50K |
|
November 12th, 2024 |
Michelle Gilson |
Chief Financial Officer |
Exercise Sale
|
26.75K |
$1.37M |
81.31K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Exercise/Conversion
|
7200 |
$8.66 |
$62.35K |
Common Stock |
Exercise/Conversion
|
7200 |
$8.66 |
$62.35K |
Common Stock |
Sale
|
9700 |
$100.26 |
$972.55K |
Common Stock |
Sale
|
1853 |
$101.27 |
$187.65K |
Common Stock |
Sale
|
801 |
$102.33 |
$81.97K |
|
November 12th, 2024 |
Kavita Patel |
Director |
Exercise
|
68.03K |
$883.19K |
51.55K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Exercise/Conversion
|
8478 |
$6.66 |
$56.46K |
Stock Option (right to buy) |
Exercise/Conversion
|
7976 |
$6.66 |
$53.12K |
Stock Option (right to buy) |
Exercise/Conversion
|
25787 |
$15.00 |
$386.81K |
Common Stock |
Exercise/Conversion
|
25787 |
$15.00 |
$386.81K |
|